- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01683812
Cranial Cup Use for Correction of Head Shape Deformities
February 9, 2017 updated by: Michele DeGrazia, Boston Children's Hospital
Cranial Cup Use for the Correction of Positional Head Shape Deformities in Hospitalized Premature Infants
The purpose of this descriptive study is to provide information on the feasibility of using the cranial cup, a new positioning device, in a small sample of prematurely born infants with elongated head shapes as a result of laying on their abdomens, during the convalescent phase of their hospitalizations.
Study Overview
Detailed Description
The cranial cup is a non-invasive, non-restrictive, adjustable orthotic device that grows with the infant and maintains proper body alignment while promoting normal head shape development.
While the cranial cup is not yet FDA approved, it is considered a non-significant medical device and it has successfully corrected asymmetric positional head shape deformities in hundreds of healthy newborns less than 4 months of age cared for by the Children's Hospital Boston outpatient plagiocephaly clinic.
Additionally preliminary analysis of a prospective randomized controlled trial currently underway suggests that the cranial cup may be useful in prevention of positional head shape deformity in a cohort of hospitalized infants of varying gestational ages.
However, the cranial cup has never been used for correction of the most common form of positional head shape deformity in hospitalized premature infants; namely dolichocephaly.
Thus, the purpose of this descriptive study is to provide information on the feasibility of using the cranial cup in a small sample of prematurely born infants with dolichocephaly during the convalescent phase of their hospitalizations.
Information obtained from this descriptive study will be used to determine if a larger investigation using the cranial cup is warranted in this specific patient population.
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Boston Children's Hospital
-
Winchester, Massachusetts, United States, 01890
- Winchester Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 1 year (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Born at < or equal to 35 weeks gestation
- Cleared for participation by healthcare team
- Estimated minimum length of stay >14 days
- Weight >1000 grams (at enrollment)
- Dolichocephalic head shape deformity
Exclusion Criteria:
- Unable to maintain airway patency (anatomical problem)
- Craniofacial anomaly or scalp device, drain or shunt
- Craniosynostosis
- Severe parturitional head shape deformity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cranial Cup Arm
Single arm
|
Study participants with dolichocephaly will be treated with the Cranial Cup for a minimum 12 hours per day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility and Safety
Time Frame: Logs of cranial cup use and desaturation and emesis events will be recorded for 14 -120 days
|
Nurses will complete daily logs indicating the number of desaturation events (oxygen saturation of < 90 percent for infant corrected to full term or < 87 percent for a premature infant for > 10 seconds) and emesis events (regurgitation of breast milk or formula) during cranial cup device use.
The cup's designated use is for at least 12 hours per day.
Study duration is at least 14 days and can continue until the infant is discharged.
Comparisons will be made for the number of desaturation events and emesis during data analysis.
|
Logs of cranial cup use and desaturation and emesis events will be recorded for 14 -120 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cranial Measurement Description
Time Frame: Using head measurements obtained at timepoint 1 enrollment (baseline, day 1) and at timepoint 2 discharge (14-120 days)
|
To describe infant head shape, the study will use cranial measurements and laser head scans in a sample of prematurely born Neonatal Intensive Care (NICU) or Special Care Nursery (SCN) patients with dolichocephaly.
Cranial measurement used is cranial index, an objective measure that quantifies head shape by dividing the head width (M-L) by length (A-P) then multiplying it by 100%.
Measurements and scans will be taken directly following study enrollment and discharge to document head shape pre and post intervention.
The discharge measure will be obtained at approximately 2 weeks-4 months of age at hospital discharge.
|
Using head measurements obtained at timepoint 1 enrollment (baseline, day 1) and at timepoint 2 discharge (14-120 days)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michele DeGrazia, PhD, Boston Children's Hospital
- Principal Investigator: Aimee Knorr, MD, Winchester Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2012
Primary Completion (Actual)
June 1, 2013
Study Completion (Actual)
June 1, 2013
Study Registration Dates
First Submitted
August 29, 2012
First Submitted That Met QC Criteria
September 10, 2012
First Posted (Estimate)
September 12, 2012
Study Record Updates
Last Update Posted (Actual)
March 29, 2017
Last Update Submitted That Met QC Criteria
February 9, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-P00003465
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dolichocephaly
-
Duke UniversityTortle Products LLCCompletedPreterm Infants | Dolichocephaly | Positional ScaphocephalyUnited States
Clinical Trials on Cranial Cup
-
Boston Children's HospitalBoston Orthotics & ProstheticsTerminatedPlagiocephaly | Brachycephaly | ScaphocephalyUnited States
-
Oslo University HospitalUniversity of OsloCompleted
-
Sahlgrenska University Hospital, SwedenCompletedProsthesis LooseningSweden
-
Touro University NevadaCompleted
-
University of GuelphAgriculture and Agri-Food Canada; Saskatchewan Pulse GrowersCompleted
-
Uppsala UniversityThe Swedish Research CouncilCompleted
-
DePuy OrthopaedicsCompletedArthritis | Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Acute FractureUnited States
-
JointResearchRecruitingOsteoarthritis, Hip | Total Hip ArthroplastyNetherlands
-
University of AarhusZimmer BiometCompletedOsteoarthritis, Hip | Arthropathy of HipDenmark
-
Northern Orthopaedic Division, DenmarkNot yet recruiting